Fed Pivots and Baby Aspirin

On Tuesday, July 16, our most reliable gauge of U.S. stock market valuations hit the steepest extreme in U.S. financial history. We cannot, and do not, assert that this places a ‘limit’ on speculation – even the previous January 2022 peak slightly exceeded the high of 1929. In our investment discipline, valuations are not enough. The uniformity or divergence of market internals is critically important (particularly following our 2021 adaptations), and we also attend to syndromes of extremely overextended market conditions. Our discipline does not rely on forecasts, scenarios, or projections of market action. Instead, we try to align our investment stance with observable, measurable market conditions as they change over the market cycle. Still, there’s a very rare set of market conditions extreme enough to deserve a ‘warning.’ As Madge said in the old Palmolive dish soap commercials, ‘you’re soaking in it.’

– John P. Hussman, Ph.D., You’re Soaking in It, July 21, 2024

From the standpoint of full-cycle investment prospects and risks, little has changed since July. Valuations remain near record extremes. Certain elements of market internals have improved somewhat despite a slight decline in the S&P 500 from its peak, but our key gauge remains in an unfavorable condition. While recent economic data have been comfortable, many reliable leading gauges remain just at the border that distinguishes expansion from recession (though we would need more evidence to expect a recession with confidence). Meanwhile, we see numerous stocks being taken behind the shed and clobbered by 10%-30% on earnings reports that are quite good but notch down guidance even slightly. When you see that behavior at extreme valuations, it tends to be a sign of underlying skittishness and risk aversion. When valuations are setting record extremes because the news can’t get any better, even a slightly less optimistic outlook becomes a risk.

As Jeremy Grantham observed a few months ago: “We have totally full employment, totally wonderful profit margins. All the things you would not want to start a bull market from. This is where you start bear markets from. Great bull markets start with exactly the opposite. You’ve got the peak P/E, so you feel wonderful, the stock market has gone up and up and up and up. So everyone feels great, and that’s how you get to a market peak. You feel great about everything. Of course, almost by definition. When do you start going down? You still feel great. You just don’t feel quite as great as you felt the day before.”

While the current level of the Federal funds rate remains consistent with systematic benchmarks that consider inflation, unemployment, real sales, economic slack, and other conditions, we do expect the Federal Reserve to cut interest rates beginning in September. Still, as I noted last month (see the section titled “Unfavorable internals dominate monetary easing, favorable internals amplify it”), even if one knew for certain that the Federal Reserve would cut interest rates over the coming 6-month period, that knowledge would not have historically justified taking a pre-emptive bullish position in the face of unfavorable internals.

As always, our investment discipline is to align our market outlook with measurable, observable market conditions. In 2021, with investors drowning in zero-interest Fed liquidity amounting to 36% of GDP, we abandoned the “ensemble methods” that embraced historically-reliable “limits” to speculation, and shifted greater emphasis to the uniformity and divergence of market internals, which since 1998 have proved to be our most reliable gauge of broad speculation versus risk-aversion.

Presently, I don’t expect a constructive shift in market internals, but as is always true, we can’t rule one out. Given current valuation extremes, any constructive shift would demand position limits and safety nets. A favorable shift in internals would not amount to a bullish “buy signal,” but it would increase our exposure to local market fluctuations without removing our defense against major downside risk. In any event, we’ll respond to market conditions as they shift. No forecasts or scenarios are required.

The chart below shows our most reliable gauge of market valuation, based on its correlation with actual subsequent 10-12 year S&P 500 total returns in market cycles across history. MarketCap/GVA is the ratio of market capitalization of U.S. nonfinancial companies to their gross-valued added, including our estimate of foreign revenues. The current level exceeds both the 1929 and 2000 market extremes.

hussman strategic